SS
LAB icon

SBI Securities’s Standard BioTools LAB Stock Holding History

SBI Securities’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133 Sell
162
-1,000
-86% -$945 ﹤0.01% 3442
2026
Q1 		$1.07K Buy
1,162
+1,000
+617% +$1.21K ﹤0.01% 2636
2025
Q4 		$207 Hold
162
– – ﹤0.01% 3202
2025
Q3 		$211 Sell
162
-100
-38% -$131 ﹤0.01% 3302
2025
Q2 		$314 Buy
262
+100
+62% +$111 ﹤0.01% 3158
2025
Q1 		$175 Hold
162
– – ﹤0.01% 3266
2024
Q4 		$284 Buy
+162
New +$302 ﹤0.01% 3110

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SBI Securities's LAB Position: Q2 2026 in Review

SBI Securities reduced its Standard BioTools (LAB) stake by 86% in Q2 2026, selling an estimated $945 and leaving 162 shares worth $133. The position accounts for ﹤0.01% of the portfolio, ranked #3442.

SBI Securities first reported a position in LAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.07K in Q1 2026. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • SBI Securities held 162 shares of Standard BioTools worth $133 as of Q2 2026.
  • SBI Securities sold 1,000 Standard BioTools shares in Q2 2026, an estimated $945.
  • Standard BioTools made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3442 holding.
  • SBI Securities first reported a position in Standard BioTools in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Standard BioTools position peaked at $1.07K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.